Continuous Monitoring of Body Temperature in Mothers and Their Preterm Neonates
MonT NeoP
1 other identifier
observational
40
1 country
1
Brief Summary
Preterm babies are at increased risk of becoming too cold or too warm immediately after birth because they have an immature ability to regulate their body temperature. Maintaining a normal body temperature during the first minutes after birth is important because both low and high body temperatures are associated with an increased risk of complications. Current temperature monitoring is performed intermittently using conventional thermometers and does not provide continuous information about changes in body temperature. This prospective observational pilot study aims to evaluate the feasibility of using the SteadyTemp® adhesive thermometer, a wireless, non-invasive temperature sensor, for continuous body temperature monitoring in preterm neonates (32+0 to 36+6 weeks of gestation) during the first 15 minutes after birth. The study will also compare temperatures recorded by the adhesive thermometer with a routine rectal temperature measurement and assess skin tolerability after removal of the adhesive patch. In addition, maternal body temperature will be continuously monitored during delivery to explore the relationship between maternal intrapartum temperature and neonatal temperature during the immediate postnatal transition. The study hypothesizes that continuous temperature monitoring with the SteadyTemp® adhesive thermometer is feasible in preterm neonates, that the recorded temperatures agree with standard rectal temperature measurements, that the device is well tolerated without clinically relevant skin irritation, and that maternal intrapartum temperature correlates with neonatal body temperature during the immediate postnatal transition. The results of this pilot study will provide preliminary evidence to support future studies evaluating continuous, non-invasive temperature monitoring as a tool to improve thermal management of preterm neonates immediately after birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedStudy Start
First participant enrolled
August 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2028
Study Completion
Last participant's last visit for all outcomes
August 15, 2028
August 11, 2026
August 1, 2026
2 years
August 6, 2026
August 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of continuous body temperature monitoring using the SteadyTemp® adhesive thermometer in preterm neonates
Feasibility will be assessed as the proportion of preterm neonates with successful placement of the SteadyTemp® adhesive thermometer and uninterrupted continuous body temperature recording during the first 15 minutes after birth.
15 minutes
Secondary Outcomes (3)
Agreement between SteadyTemp® and rectal body temperature measurements
15 minutes after birth (at the time of routine rectal temperature measurement).
Neonatal skin tolerability after application of the SteadyTemp® adhesive thermometer
Immediately after removal of the adhesive thermometer (15 minutes after birth).
Association between maternal intrapartum temperature and neonatal body temperature during immediate postnatal transition
From approximately 10 minutes before birth until 15 minutes after birth.
Study Arms (1)
Mother-Preterm Neonate Pairs
The study cohort consists of mother-preterm neonate pairs. Preterm neonates will undergo continuous body temperature monitoring using the SteadyTemp® adhesive thermometer during the first 15 minutes after birth, while mothers will undergo continuous intrapartum temperature monitoring during delivery. Neonatal temperatures will be compared with a routine single rectal temperature measurement, and maternal and neonatal temperature profiles will be explored to assess their relationship during the immediate postnatal transition.
Interventions
SteadyTemp® (SteadySense GmbH, Graz, Austria) is a wireless, non-invasive adhesive thermometer designed for continuous body temperature monitoring. In this study, one adhesive thermometer will be applied to the mother's skin at least 10 minutes before delivery for continuous intrapartum temperature monitoring, and a second thermometer will be applied to the preterm neonate's right axillary region immediately after birth for continuous temperature monitoring during the first 15 minutes of postnatal transition. Temperature data are recorded continuously and transferred via near-field communication (NFC). The device is used in addition to standard clinical care and does not replace routine rectal temperature measurement, which serves as the clinical reference standard.
Eligibility Criteria
The study population consists of preterm neonates born between 32+0 and 36+6 weeks of gestation and their mothers at the Department of Obstetrics and Gynaecology of the Medical University of Graz, Austria, and the University Hospital Essen, Germany. Eligible mother-preterm neonate pairs will be recruited before delivery after written informed consent has been obtained. Neonates will undergo routine postnatal care, with additional continuous temperature monitoring using the investigational device during the immediate postnatal transition.
You may qualify if:
- Preterm neonates born between 32+0 and 36+6 weeks of gestation.
- Written informed consent obtained from the mother (or legally authorized representative, where applicable according to national legislation) before delivery and before any study-specific procedures are performed.
You may not qualify if:
- Gestational age \<32+0 weeks or ≥37+0 weeks.
- No decision to conduct full life support.
- Written informed consent not obtained before delivery.
- Congenital malformation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Grazlead
- Universität Duisburg-Essencollaborator
Study Sites (1)
Medical University Graz
Graz, Styria, 8034, Austria
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2026
First Posted
August 11, 2026
Study Start (Estimated)
August 15, 2026
Primary Completion (Estimated)
August 15, 2028
Study Completion (Estimated)
August 15, 2028
Last Updated
August 11, 2026
Record last verified: 2026-08